M85.08 Fibrous dysplasia (monostotic), other site

Name of the Condition

• Fibrous Dysplasia (Monostotic), Other Site (ICD-10 Code: M85.08)
• A benign bone disorder characterized by abnormal fibrous tissue replacing normal bone, affecting a single bone at a site other than those specified elsewhere in the classification.

Summary

Fibrous dysplasia (monostotic), other site, is a condition where fibrous tissue abnormally replaces normal bone in one area of the skeleton, excluding sites like the shoulder, skull, or long bones of the extremities. This can weaken the bone, potentially leading to deformity or fracture. The term "other site" indicates the affected location is documented but not categorized under more specific codes.

Causes

The exact cause is unknown, but it involves a genetic mutation affecting bone-forming cells. The mutation leads to abnormal development of bone tissue, resulting in a mix of fibrous and osseous material. It is not typically inherited and occurs sporadically.

Risk Factors

• Age: Most commonly diagnosed in children and young adults.
• Gender: Slightly more prevalent in females.
• No known environmental or lifestyle risk factors have been identified.

Symptoms

• Bone pain or aching, often worsening with activity.
• Swelling or deformity in the affected area.
• Increased risk of fractures from minor trauma.
• Asymptomatic in some cases, discovered incidentally on imaging.

Diagnosis

Diagnosis is based on clinical evaluation, imaging, and sometimes biopsy. X-rays or CT scans show characteristic "ground-glass" appearance of affected bone. MRI may be used to assess soft tissue involvement. Biopsy confirms fibrous tissue replacement of bone.

Treatment Options

Treatment depends on symptoms and severity. Mild cases may require monitoring. Pain management or physical therapy addresses discomfort. Surgical intervention (e.g., bone grafting, corrective osteotomy) may be needed for deformity or fracture risk. Bisphosphonates are sometimes used to reduce pain and bone turnover.

Prognosis and Follow-Up

Prognosis is generally good, as the condition is non-cancerous. Most cases are stable or progress slowly. Regular follow-up with imaging monitors for changes. Complications like fractures or deformity may require ongoing management.

Complications

• Pathologic fractures from weakened bone.
• Bone deformity affecting function or appearance.
• Rarely, malignant transformation (very uncommon).

Lifestyle & Prevention

No specific prevention exists. Maintaining bone health through adequate calcium and vitamin D intake supports overall skeletal strength. Avoid high-impact activities if fracture risk is elevated.

When to Seek Professional Help

Seek care if experiencing persistent bone pain, swelling, or new deformity. Immediate evaluation is needed for sudden pain suggesting fracture. Regular follow-up is recommended for diagnosed cases to monitor for changes.

Tips for Medical Coders

Document the specific site of fibrous dysplasia (monostotic) when known, as this determines code assignment. Use M85.08 for sites not covered by more specific codes (e.g., vertebrae, pelvis, ribs). Ensure clinical documentation supports the "other site" designation to justify code selection.